Abstract: Zeolites having surface modification with graphene oxide, reduced graphene oxide, or a sulfide have utility in removing pollutants from a water supply. Pollutants include Persistent Organic Pollutants (POPs) and heavy metals, such as lead. POPs are adsorbed onto zeolites having surface modification with graphene oxide and/or reduced graphene oxide. Heavy metals are adsorbed onto zeolites having surface modification with a sulfide.

Abstract: Zeolites functionalized with graphene oxide, reduced graphene oxide, or a sulfide have utility in removing pollutants from a water supply. Pollutants include Persistent Organic Pollutants (POPs) and heavy metals, such as lead.

Abstract: The subject invention provides an antibody composition for detecting E6 protein of at least one HPV strain in a sample. The subject antibodies may be used to detect oncogenic HPV E6 proteins in a sample, and the antibodies find use in a variety of diagnostic and therapeutic applications, including methods of diagnosing and treating cancer. Kits for performing the subject methods and containing the subject antibodies are also provided. Also disclosed in the present invention is a method of generating an antibody that specifically binds to amino-terminus of E6 proteins of at least two HPV strains.

Abstract: This invention relates to methods of screening for modulators of mammalian cell injury cause by TRPM7 gene and protein activity, compounds that modulate TRPM7 gene and protein activity and methods of treatment of mammalian cell injury using modulators of TRPM7 gene and protein activity.

Abstract: The present invention relates to compositions for use in the modulation of PDZ domain interactions with cognate ligands. Methods of assessing and characterizing PDZ domain interactions from various polypeptides also are provided.

Abstract: The invention provides methods of treating or effecting prophylaxis of a patient having or at risk of developing symptoms of anxiety in which an effective regime of an agent that inhibits specific binding of PSD95 to an NMDA receptor is administered to a patient.

Abstract: The subject invention provides an antibody composition for detecting E6 protein of at least one HPV strain in a sample. The subject antibodies may be used to detect oncogenic HPV E6 proteins in a sample, and the antibodies find use in a variety of diagnostic and therapeutic applications, including methods of diagnosing and treating cancer. Kits for performing the subject methods and containing the subject antibodies are also provided. Also disclosed in the present invention is a method of generating an antibody that specifically binds to amino-terminus of E6 proteins of at least two HPV strains.

Abstract: The invention provides methods of treating or effecting prophylaxis of a patient having or at risk of developing symptoms of anxiety in which an effective regime of an agent that inhibits specific binding of PSD95 to an NMDA receptor is administered to a patient.

Abstract: The invention provides methods of treating or effecting prophylaxis of a patient having or at risk of developing symptoms of anxiety in which an effective regime of an agent that inhibits specific binding of PSD95 to an NMDA receptor is administered to a patient.

Abstract: A method of incorporating a material in a settable binder is disclosed. The binder includes a source of caustic magnesium oxide. The method involves mixing the material with the binder, either as part of a slurry or for subsequent formation into a slurry, and then adding a setting agent to the slurry. The setting agent is added to enhance setting of the binder. The material can be a hazardous waste material or components thereof. The inventors have surprisingly discovered that when the setting agent is added after mixing of the material with the binder, that a superior setting of the material in the binder can be achieved. The settable composition can comprise only a caustic magnesium oxide binder and a setting agent for the binder, as the inventors have surprisingly discovered that there is no need for any other binding agents, thus providing a simpler binder composition and method of use.

Abstract: The present invention relates to compositions for use in the modulation of PDZ domain interactions with cognate ligands. Methods of assessing and characterizing PDZ domain interactions from various polypeptides also are provided.

Abstract: The invention provides methods of treating or effecting prophylaxis of a patient having or at risk of developing symptoms of anxiety in which an effective regime of an agent that inhibits specific binding of PSD95 to an NMDA receptor is administered to a patient.

Abstract: A method of incorporating a material in a settable binder is disclosed. The binder includes a source of caustic magnesium oxide. The method involves mixing the material with the binder, either as part of a slurry or for subsequent formation into a slurry, and then adding a setting agent to the slurry. The setting agent is added to enhance setting of the binder. The material can be a hazardous waste material or components thereof. The inventors have surprisingly discovered that when the setting agent is added after mixing of the material with the binder, that a superior setting of the material in the binder can be achieved. The settable composition can comprise only a caustic magnesium oxide binder and a setting agent for the binder, as the inventors have surprisingly discovered that there is no need for any other binding agents, thus providing a simpler binder composition and method of use.